Home > Boards > Free Zone > Penny Trading - Technical > BB's Stock Haven

$PBIO news here: Pressure BioSciences, Inc. (PBIO) (“PBI”

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
budfoxfun Member Profile
Member Level 
Followed By 877
Posts 322,884
Boards Moderated 3
Alias Born 06/24/11
160x600 placeholder
UniCredit's Mustier to Step Down as CEO Over Strategy Rift -- 2nd Update
ROME -- UniCredit Chief Executive Jean Pierre Mustier will step down in April over a rift with the board over future strategy at Italy's second largest lender.
Zoom's Pandemic-Fueled Boom Continues -- 2nd Update
General Motors Will No Longer Take a Stake in Nikola -- 5th Update
Top Stories of the Day
Exxon Slashes Spending, Writes Down Assets
Top Company News of the Day
CSX Agrees to Acquire New England's Pan Am Railways
Zoom's Pandemic-Fueled Boom Continues -- Update
Powell Says Fed Actions Unlocked $2 Trillion to Support Economy
Zoom's Pandemic-Fueled Boom Continues
Zoom's Shares Fall Despite 3Q Profit, Sales Beat
Dow Falls, but Holds On for Best Month in Over Three Decades
USDA Crop Progress: Winter Wheat Condition/Progress-Nov 30
Labor Department Published 'Flawed Estimates' of Weekly Jobless Claims, Watchdog Says -- Update
UniCredit CEO Jean Pierre Mustier to Leave Bank in April -- Update
Wheat Falls on Signs of Russian Quota Growth
UniCredit CEO Jean Pierre Mustier to Leave Bank in April
USDA Oct Farm Prices - Nov 30
Dow Falls, But Remains on Track for Best Month in Over Three Decades
General Motors Will No Longer Take a Stake in Nikola -- 4th Update
November Payrolls Growth Expected to Slow -- Data Week Ahead Update
Veritone Up 35% As Operating System Supports Nvidia Platform
Nikola Teaches GM a Lesson -- Heard on the Street
Facebook to Acquire Kustomer in Deal That Values Startup at $1 Billion -- 2nd Update
budfoxfun Member Level  Monday, 11/25/19 06:43:23 AM
Re: None
Post # of 4703120 
$PBIO news here: Pressure BioSciences, Inc. (PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the Company’s patented pressure cycling technology (“PCT”) platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples. This workflow was presented in a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September 21, 2019 in Rio de Janeiro, Brazil.



According to Dr. Larry Maxwell, MD, gynecologic oncologist and Chair of OB-GYN at Inova Fairfax Hospital, “the conventional use of chemotherapy in ovarian cancer treatment is being rapidly replaced by biologic therapeutics that target the cancer (the “seed”) and also the micro-environment (the “soil”) in which it grows. Being able to collect small tissue specimens and characterize them across multiple genomic and proteomic platforms will enable us to markedly enhance our ability to develop companion diagnostics and prognostics as well as identify targets for future therapeutic strategies. Technology provided by Pressure BioSciences has become an essential requirement for our novel workflow in meeting our goals ”

The mission of the IGCS is to improve the care and outcomes for women with gynecologic cancer worldwide through education, training and public awareness


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences